Fundraising Fox
🦊/Companies
Sign in

Dynavax NASDAQ: DVAX www.dynavax.com

Düsseldorf, DE · 258 employees on LinkedIn · 1 known investors

Find your way into Dynavax NASDAQ: DVAX www.dynavax.com

926 people in our graph share verified history with the Dynavax NASDAQ: DVAX www.dynavax.com team — schools, employers, funds. One of them is your warm intro.

Laura Buhlerunlockedknows Andrew Davis · together at McKinsey & Company (overlapped)
×10knows the team · via McKinsey & Company
knows the team · via California Polytechnic State University-San Luis Obispo

Dynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology. Its products target immunization and infectious disease prevention.

BiotechHealthtech

Founders & leadership

RSRyan Spencer
Ryan SpencerinChief Executive Officer
DNDavid Novack
David NovackinPresident and Chief Operating Officer
RJRobert Janssen
Robert JansseninChief Medical Officer and Senior Vice President, Clinical Development
KMKelly MacDonald
Kelly MacDonaldinChief Financial Officer
JCJeff Coon
Jeff CoonChief Human Resources Officer
DCDonn Casale
Donn CasaleinChief Commercial OfficerCasale is Chief Commercial Officer at Dynavax, a biopharmaceutical company developing vaccines using adjuvant technology. He has over 25 years of experience in biopharmaceutical commercial leadership, including scaling the company's U.S. commercial platform and growing HEPLISAV-B revenue from $62M in 2021 to over $300M annualized by 2025, and has led commercial strategy across vaccines, infectious disease, pain, and neurology across various roles.
ADAndrew Davis
Andrew DavisinChief Business OfficerAndrew Davis is Chief Business Officer at Dynavax, a vaccine company using adjuvant technology for infectious disease prevention. He brings extensive experience in corporate development and strategy, including numerous mergers, acquisitions, licensing deals, and partnerships across multiple therapeutic areas including dermatology, ophthalmology, and oncology.

Investors · 1

Sanderling VenturesSan Mateo · $50K – $1M

Competitors · 1

by search overlap
Medscape101 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with Dynavax NASDAQ: DVAX www.dynavax.com for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 11 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$1M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2013$223.4K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$599K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$404.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2011$595.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2010$595.8K
National Institutes of Health (NIH)National Institutes of HealthPhase I2009$720.3K
National Institutes of Health (NIH)National Institutes of HealthPhase II2008$1.8M
National Institutes of Health (NIH)National Institutes of HealthPhase I2006$207.3K
National Institutes of Health (NIH)National Institutes of HealthPhase I2002$119.3K
National Institutes of Health (NIH)National Institutes of HealthPhase I2000$100K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Dynavax NASDAQ: DVAX www.dynavax.com do?
Dynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology. Its products target immunization and infectious disease prevention.
Who are Dynavax NASDAQ: DVAX www.dynavax.com's investors?
Dynavax NASDAQ: DVAX www.dynavax.com's investors include Sanderling Ventures.
Where is Dynavax NASDAQ: DVAX www.dynavax.com headquartered?
Dynavax NASDAQ: DVAX www.dynavax.com is headquartered in Düsseldorf, DE.